Real-World Evidence of Safety and Efficacy of Carboplatin plus Nanoparticle Albumin-Bound Paclitaxel in Patients with Advanced Non-Small-Cell Lung Cancer and Preexisting Interstitial Lung Disease: A Retrospective Study

Table 3

Objective tumor response.

Response	No. of patients
Complete response	0
Partial response	7
Stable disease	1
Progressive disease	1
Response rate (%)	77.8
Disease control rate (%)	88.9